At ASHG in Boston, Eric Green received the society's Leadership Award and delivered an acceptance speech that moved the entire room.
Study findings suggest using the drug PF-06409577 to restore CDX2 in colon cancers could cut risk of recurrence and death by up to 50%.
Researchers now know that MS starts way earlier than the clinical onset, creating the real possibility that MS could one day be controlled.
BioAgilytix now operates 355,000-square-feet of laboratory facilities, including 24,000-square-feet dedicated to LC/MS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback